DKA INVEST ApS: Financial statements 2017
CVR: 26007496
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
DKA INVEST ApS (CVR 26007496) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -29,710 compared with DKK -229,581 the year before. Equity in the 2017 report amounted to DKK 97,088. The solvency ratio was 61.1%.
- Profit/Loss
- DKK -29,710
- Equity
- DKK 97,088
- Total Assets
- DKK 158,811
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | -30K | 97K | - |
| 2016 | - | - | -230K | 127K | - |
| 2015 | - | -1 | 7.5M | -508K | - |
| 2014 | - | 1 | 14.5M | -8M | - |
| 2013 | - | - | -2.3M | -22.6M | - |
Official annual report
Keep an eye on DKA INVEST ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
DKA INVEST ApS has published its annual report for 2016. The net result was DKK -229,581.
About DKA INVEST ApS
DKA INVEST ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2001. The company has been dissolved on 22 March 2022. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named IMMUNOLEX HOLDING ApS and EEQX ApS. In 2020, the company reported a net result of DKK -16,021 compared with DKK -18,421 the year before. Equity in the 2020 report amounted to DKK 44,950.